Abstract
We report a patient with multifocal motor neuropathy (MMN) who experienced a paradoxical decline in baseline strength to below pretreatment levels during a period of improvement associated with human immunoglobulin (HIG) administration. This outcome suggests that HIG may not limit progression of MMN and may reduce the utility of HIG as chronic therapy.
Original language | English (US) |
---|---|
Pages (from-to) | 967-968 |
Number of pages | 2 |
Journal | Neurology |
Volume | 44 |
Issue number | 5 |
DOIs | |
State | Published - May 1994 |
ASJC Scopus subject areas
- Clinical Neurology